Lucira Health (LHDX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 109 252 sessions, March 3, 2022 to March 3, 2023
- Largest daily move
- +440.1% close of January 3, 2023
- 1-year change
- -90% closing prices, March 3, 2022 to March 3, 2023
- 1-month change
- +33.1% closing prices, February 3, 2023 to March 3, 2023
Company Description
Lucira Health (Nasdaq: LHDX) is classified in the medical devices industry within the Healthcare sector.
LHDX has declined 90.0% over the past year. The last closing price was $0.4523.
This page collects what Stock Titan holds for LHDX, including price data and latest news.
Stock Performance
Lucira Health (LHDX) closed at $0.4523 on March 3, 2023. Over the past 12 months, the price has lost 90.0%.
LHDX Metrics & Rankings
Price returns through March 3, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Lucira Health has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include covid-19, fda approval, partnership, earnings. View all LHDX news →
SEC Filings
LHDX Company Profile & Sector Positioning
Lucira Health (LHDX) operates in the Medical Devices industry within the broader Healthcare sector.
Investors comparing LHDX often look at related companies in the same sector, including Pheton Holdings Ltd (PTHL), ALR Technologies, Inc. (ALRT), ALLURION TECHNOLOGIES (ALUR), Ainos, Inc. (AIMD), and Profusa, Inc. (PFSA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LHDX's relative position within its industry.